Literature DB >> 9120966

Resolution rates of low grade vesicoureteral reflux stratified by patient age at presentation.

S P Greenfield1, M Ng, J Wan.   

Abstract

PURPOSE: Most children with grades I to III primary vesicoureteral reflux are monitored for years on antibiotic prophylaxis until reflux resolves. While the overall resolution rate of these grades is known, the rates for various patient ages at presentation are unknown. Therefore, we examined resolution rates of these grades for different ages at presentation.
MATERIALS AND METHODS: From 1985 through 1990, 168 boys (245 ureters) and 433 girls (590 ureters) with all grades of reflux were enrolled in the study and monitored through the end of 1993. Urine cultures were obtained every 4 months and contrast voiding cystourethrography was repeated every 18 months. Age at presentation was stratified into groups younger than 1, 1 to 3, 4 to 6, 7 to 9, and 10 years and older. Resolution rates were then calculated for grades I to III reflux for each age at presentation. Time to resolution was also evaluated for each age and grade.
RESULTS: There were no significant differences between rates of resolution at different ages for each grade. Children less than 10 years old had as high a likelihood of resolution as infants. Neither sex nor bilaterality versus unilaterality was a helpful predictor of resolution. Time to resolution varied widely and it was also not helpful for identifying the cases of reflux that resolved.
CONCLUSIONS: Low grade vesicoureteral reflux may not resolve until adolescence and age at presentation is not a reliable predictive factor. Children should remain on prophylaxis for many years unless definitive correction is undertaken.

Entities:  

Mesh:

Year:  1997        PMID: 9120966

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Compliance with antibiotic prophylaxis in children with vesicoureteral reflux: results from a national pharmacy claims database.

Authors:  Hillary L Copp; Caleb P Nelson; Linda D Shortliffe; Julie Lai; Christopher S Saigal; William A Kennedy
Journal:  J Urol       Date:  2010-03-19       Impact factor: 7.450

Review 2.  Therapy for vesicoureteral reflux: antibiotic prophylaxis, urotherapy, open surgery, endoscopic injection, or observation?

Authors:  Jack S Elder
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

3.  Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study.

Authors:  Ron Keren; Myra A Carpenter; Alejandro Hoberman; Nader Shaikh; Tej K Matoo; Russell W Chesney; Ranjiv Matthews; Arlene C Gerson; Saul P Greenfield; Barbara Fivush; Gordon A McLurie; H Gil Rushton; Douglas Canning; Caleb P Nelson; Lawrence Greenbaum; Timothy Bukowski; William Primack; Richard Sutherland; James Hosking; Dawn Stewart; Jack Elder; Marva Moxey-Mims; Leroy Nyberg
Journal:  Pediatrics       Date:  2008-12       Impact factor: 7.124

4.  Adherence to antibiotic prophylaxis in children with vesicoureteral reflux.

Authors:  Esequiel Rodriguez; Dana A Weiss; Hillary L Copp
Journal:  Adv Urol       Date:  2011-03-27

5.  Increasing the Reliability of the Grading System for Voiding Cystourethrograms Using Ultrasonography: An Inter-Rater Comparison.

Authors:  Seyithan Ozaydin; Suleyman Celebi; Ismail Caymaz; Cemile Besik; Birgul Karaaslan; Ozgur Kuzdan; Serdar Sander
Journal:  Nephrourol Mon       Date:  2016-07-31

Review 6.  Management of vesicoureteral reflux in children.

Authors:  S P Greenfield
Journal:  Curr Urol Rep       Date:  2001-04       Impact factor: 2.862

7.  Reliability of the Grading System for Voiding Cystourethrograms in the Management of Vesicoureteral Reflux: An Interrater Comparison.

Authors:  Süleyman Çelebi; Seyithan Özaydın; Cemile Beşik Baştaş; Özgür Kuzdan; Cankat Erdoğan; Mehmet Yazıcı; İsmail Caymaz; Serdar Sander
Journal:  Adv Urol       Date:  2016-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.